Delivery Order SPE2DB20D2104-SPE2DB23FT71D

Award Date 5/26/23
Potential Completion Date 5/30/23
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $2,227.17. The order is for the medication Trulicity 1.5 mg/0.5 ml pen with a completion date of January 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical through November 2026. The IDC covers a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $1,035.96 and a period of performance through July 19, 2024. It is a firm-fixed-price contract for the delivery of this specific pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Trulicity (1.5 mg/0.5 ml pen) with a ceiling value of $3,937.94. The award is issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pens. The $1,161.12 firm fixed-price contract has an ultimate completion date of April 20, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract has a firm fixed price of $25,942.97 and a completion date of March 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Trulicity (3 mg/0.5 mL) under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order has a ceiling value of $2,495.77 and a completion date of November 19, 2024. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds this IDC with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $1,801.80 and an ultimate completion date of January 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $1,501.50, is for the Trulicity 3 mg/0.5 ml pen 0.5 ml medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary contracting vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $4,618.97 and runs through January 14, 2025. This award is associated with a broader Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and in effect through November 2026. The IDC serves as a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FT71D
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order is for the medication Trulicity 1.5 mg/0.5 ml pen with a ceiling value of $2,612.52 and a completion date of May 30, 2023. The contract is a firm fixed-price arrangement. There is no set-aside designation mentioned, indicating open competition. This contract supports the DLA's role in providing pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/27/25, 1:23 PM